[Birdshot retinochoroidopathy: Key messages]

Area of Science:

• Ophthalmology
• Immunology
• Genetics

Background:

• Birdshot retinochoroidopathy (BRC) is a severe posterior autoimmune uveitis.
• It is strongly linked to the HLA A29 phenotype in Caucasian individuals.
• Delayed appearance of characteristic fundus lesions can complicate early diagnosis.

Purpose of the Study:

• To highlight the importance of ancillary diagnostic and follow-up tests for BRC.
• To emphasize the need for timely and aggressive treatment strategies.
• To improve the prognosis for patients with Birdshot retinochoroidopathy.

Main Methods:

• Review of clinical presentation and diagnostic tools for BRC.
• Discussion of ancillary tests including optical coherence tomography (OCT), fluorescein angiography (FA), and indocyanine green angiography (ICGA).
• Evaluation of electroretinograms (ERGs) and visual field testing for disease monitoring.

Main Results:

• Visual acuity is an unreliable indicator of visual function in BRC.
• OCT can detect macular edema or atrophy.
• Angiography and electrophysiological tests provide crucial diagnostic and prognostic information.

Conclusions:

• Comprehensive clinical and paraclinical evaluations are essential for optimal BRC patient management.
• Early initiation of corticosteroids combined with immunosuppressive therapy is recommended, especially with poor prognostic factors.
• Regular patient follow-up ensures the best possible visual outcomes.